Form 8-K - Current report:
SEC Accession No. 0001213900-14-007389
Filing Date
2014-10-21
Accepted
2014-10-21 08:31:40
Documents
45
Period of Report
2014-10-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k102114_actiniumpharma.htm 8-K 24985
2 KOL EVENT LEAD PROGRAMS OVERVIEW PRESENTATION. f8k102114ex99i_actinium.htm EX-99.1 9424
3 KOL PRESENTATION, DATED OCTOBER 21, 2014. f8k102114ex99ii_actinium.htm EX-99.2 29120
4 GRAPHIC slide1.jpg GRAPHIC 117397
5 GRAPHIC slide2.jpg GRAPHIC 111702
6 GRAPHIC slide3.jpg GRAPHIC 120702
7 GRAPHIC slide4.jpg GRAPHIC 114946
8 GRAPHIC slide5.jpg GRAPHIC 104694
9 GRAPHIC slide6.jpg GRAPHIC 176070
10 GRAPHIC slide7.jpg GRAPHIC 87909
11 GRAPHIC slide8.jpg GRAPHIC 135458
12 GRAPHIC slide9.jpg GRAPHIC 91667
13 GRAPHIC slide10.jpg GRAPHIC 91638
14 GRAPHIC slide11.jpg GRAPHIC 157765
15 GRAPHIC slide12.jpg GRAPHIC 170338
16 GRAPHIC slide13.jpg GRAPHIC 219605
17 GRAPHIC slide14.jpg GRAPHIC 182721
18 GRAPHIC slide15.jpg GRAPHIC 206909
19 GRAPHIC slide16.jpg GRAPHIC 122133
20 GRAPHIC slide17.jpg GRAPHIC 209629
21 GRAPHIC slide18.jpg GRAPHIC 156948
22 GRAPHIC slide19.jpg GRAPHIC 164237
23 GRAPHIC slide20.jpg GRAPHIC 91379
24 GRAPHIC slide21.jpg GRAPHIC 163490
25 GRAPHIC slide22.jpg GRAPHIC 112712
26 GRAPHIC slide23.jpg GRAPHIC 126527
27 GRAPHIC slide24.jpg GRAPHIC 99229
28 GRAPHIC slide25.jpg GRAPHIC 121213
29 GRAPHIC slide26.jpg GRAPHIC 155307
30 GRAPHIC slide27.jpg GRAPHIC 88628
31 GRAPHIC slide28.jpg GRAPHIC 95587
32 GRAPHIC slide29.jpg GRAPHIC 175883
33 GRAPHIC slide30.jpg GRAPHIC 154039
34 GRAPHIC slide31.jpg GRAPHIC 190286
35 GRAPHIC img1.jpg GRAPHIC 37873
36 GRAPHIC img2.jpg GRAPHIC 110173
37 GRAPHIC img3.jpg GRAPHIC 31858
38 GRAPHIC img4.jpg GRAPHIC 53167
39 GRAPHIC img5.jpg GRAPHIC 51384
40 GRAPHIC img6.jpg GRAPHIC 47673
41 GRAPHIC img7.jpg GRAPHIC 40071
42 GRAPHIC img8.jpg GRAPHIC 51305
43 GRAPHIC img9.jpg GRAPHIC 63168
44 GRAPHIC img10.jpg GRAPHIC 40048
45 GRAPHIC img11.jpg GRAPHIC 37873
  Complete submission text file 0001213900-14-007389.txt   6795847
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 141164944
SIC: 2834 Pharmaceutical Preparations